Family Medicine · Glendale, CA
NPI
1477723203
Since 2008
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
435 Arden Ave Ste 360
Glendale, CA, 91203
Phone (818) 637-8300
Groups this clinician bills Medicare through
Medicare paid, 2024
$514K
9,144 services
Medicare patients, 2024
626
Average age 75
Drug cost, 2024
$3.8M
30,824 prescriptions
Company payments, 2025
$2,366
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vigen Khojayan was code 99490 (chronic, principal, and transitional care management), 2,759 times for 524 patients. In total Vigen Khojayan billed 9,144 services in 29 codes, and Medicare paid $514K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-12-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 2,759 | 524 | $43.18 | $119K |
| 99442 Telephone Services | Office | 1,270 | 443 | $73.93 | $94K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,074 | 432 | $12.87 | $14K |
| 99232 Hospital E&M - Subsequent | Facility | 866 | 104 | $61.59 | $53K |
| 99213 Office E&M - Established | Office | 657 | 334 | $74.01 | $49K |
| 99214 Office E&M - Established | Office | 284 | 250 | $92.70 | $26K |
| 99233 Hospital E&M - Subsequent | Facility | 282 | 121 | $92.63 | $26K |
| 36415 Venipuncture Blood Collection | Office | 240 | 207 | $7.99 | $1,919 |
| 99239 Hospital Discharge Management | Facility | 208 | 126 | $90.37 | $19K |
| 99222 Hospital E&M - Initial | Facility | 208 | 131 | $101.83 | $21K |
| 82962 Clinical Chemistry | Office | 201 | 122 | $3.21 | $645 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 178 | 178 | $19.96 | $3,553 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 173 | 118 | $223.32 | $39K |
| 96372 Injection Administration | Office | 135 | 48 | $11.89 | $1,606 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 120 | 53 | $74.52 | $8,942 |
By year: 2022 $519K for 7,576 services; 2023 $563K for 7,890 services; 2024 $514K for 9,144 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 240 | 207 | $7.99 | $1,919 |
| 82962 Clinical Chemistry | 201 | 122 | $3.21 | $645 |
Medicare prescription drug claims, 2024
In 2024, the drug Vigen Khojayan prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,749 prescriptions and refills. In total Vigen Khojayan wrote 30,824 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,749 | 2,413 | 253 | $5,899 |
| Amlodipine Besylate Generic | 1,260 | 1,612 | 186 | $2,336 |
| Losartan Potassium Generic | 945 | 1,304 | 152 | $4,239 |
| Hydralazine Hcl Generic | 889 | 971 | 122 | $4,079 |
| Levothyroxine Sodium Generic | 854 | 1,093 | 101 | $3,360 |
| Metformin Hcl Generic | 745 | 956 | 112 | $2,172 |
| Rosuvastatin Calcium Generic | 582 | 744 | 84 | $2,970 |
| Omeprazole Generic | 570 | 715 | 82 | $2,292 |
| Tamsulosin Hcl Generic | 556 | 729 | 83 | $3,471 |
| Gabapentin Generic | 527 | 603 | 77 | $2,501 |
| Metoprolol Succinate Generic | 527 | 677 | 75 | $3,178 |
| Diclofenac Sodium Generic | 513 | 598 | 101 | $169K |
| Pantoprazole Sodium Generic | 488 | 576 | 82 | $2,001 |
| Ibuprofen Generic | 472 | 477 | 82 | $2,266 |
| Vascepa Icosapent Ethyl | 471 | 549 | 82 | $163K |
Brand drugs: 4,874 claims; generic drugs: 25,505 claims; opioid claims: 355.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vigen Khojayan $2,366 ($2,366 in general payments such as food, travel and fees) from 24 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $263.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 12 | $263 |
| Ardelyx, Inc. ARDX | 8 | $256 |
| Abbvie Inc. ABBV | 11 | $220 |
| Shield Therapeutics Inc STX.L | 17 | $184 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $179 |
| Aimmune Therapeutics, Inc. | 5 | $154 |
| Amgen Inc. AMGN | 10 | $152 |
| Novo Nordisk Inc NVO | 5 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $112 |
| Lilly USA, LLC LLY | 5 | $103 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.